Synapse - Works

Results (601)

The potential benefit of allogeneic over autologous transplantation in patients with very early relapsed and refractory follicular lymphoma with prior remission duration of <= 12 months

Journal Article

Lunning, M. A.; Migliacci, J. C.; Hilden, P.; Devlin, S. M.; Castro-Malaspina, H.; Giralt, S.; Perales, M. A.; Zelenetz, A. D.; Moskowitz, C. H.; Sauter, C. S.
British Journal of Haematology (2016)

Fulltext@MSK | Save

Increased GVHD-related mortality with broad-spectrum antibiotic use after allogeneic hematopoietic stem cell transplantation in human patients and mice

Journal Article

Shono, Y.; Docampo, M. D.; Peled, J. U.; Perobelli, S. M.; Velardi, E.; Tsai, J. J.; Slingerland, A. E.; Smith, O. M.; Young, L. F.; Gupta, J.; more...
Science Translational Medicine (2016)

Fulltext@MSK | Save

Success of an international learning healthcare system in hematopoietic cell transplantation: The American Society of Blood and Marrow Transplantation Clinical Case Forum

Meeting Abstract

Barba, P.; Burns, L.; Litzow, M.; Juckett, M.; Komanduri, K.; Lee, S.; Devlin, S.; Costa, L.; Khan, S.; Klein, A.; more...
Bone Marrow Transplantation (2016)

Fulltext@MSK | Save

CD34+ selected ex-vivo T-cell depleted grafts for allogeneic hematopoietic cell transplantation is associated with low incidence of acute and chronic graft-versus-host disease (GVHD) and high chronic-GVHD/relapse-free survival

Meeting Abstract

Barba, P.; Hilden, P.; Devlin, S.; Maloy, M.; Barker, J.; Castro-Malaspina, H.; Jakubowski, A.; Koehne, G.; Papadopoulos, E.; Sauter, C.; more...
Bone Marrow Transplantation (2016)

Fulltext@MSK | Save

Toxicities in older adult patients undergoing CD34+ selected allogeneic hematopoietic stem cell transplantation (allo-HCT)

Meeting Abstract

Shah, G. L.; Scordo, M.; Kosuri, S.; Herrera, D. A.; Maloy, M.; Nieves, J. L.; Devlin, S.; Avecilla, S. T.; Meagher, R.; Shaffer, B.; more...
Bone Marrow Transplantation (2016)

Fulltext@MSK | Save

Late toxicities in long-term survivors of adult allogeneic hematopoietic cell transplantation (allo-HCT) using ex-vivo CD34+ selection-based graft-versus-host disease (GVHD) prophylaxis

Meeting Abstract

Scordo, M.; Shah, G. L.; Devlin, S.; Maloy, M.; Kosuri, S.; Herrera, D. A.; Nieves, J.; Avecilla, S. T.; Meagher, R. C.; Gyurkocza, B.; more...
Bone Marrow Transplantation (2016)

Fulltext@MSK | Save

Acute toxicities in patients receiving ex-vivo CD34+ selected allogeneic stem cell transplantation for hematologic malignancies

Meeting Abstract

Herrera, D.; Perales, M. A.; Shah, G.; Scordo, M.; Devlin, S.; Maloy, M.; Nieves, J.; Avecilla, S.; Meagher, R.; Gyurkocza, B.; more...
Bone Marrow Transplantation (2016)

Fulltext@MSK | Save

Myeloablative conditioning and CD34+ selection results in higher chronic-GVHD free/relapse free-survival compared to reduced-intensity conditioning and unmodified graft in patients with AML and MDS > 50 years receiving HLA-matched allogeneic HCT

Meeting Abstract

Barba, P.; Martino, R.; Zhou, Q.; Cho, C.; Castro-Malaspina, H.; Devlin, S.; Esquirol, A.; Giralt, S.; Jakubowski, A.; Lopez-Corral, L.; more...
Bone Marrow Transplantation (2016)

Fulltext@MSK | Save

Long-term prognosis of one-year survivors of CD34-selected allogeneic hematopoietic stem cell transplantation: A landmark analysis

Meeting Abstract

Cho, C.; Hsu, M.; Avecilla, S.; Barba, P.; Barker, J.; Castro-Malaspina, H.; Devlin, S.; Giralt, S.; Jakubowski, A.; Koehne, G.; more...
Bone Marrow Transplantation (2016)

Fulltext@MSK | Save

Sirolimus, tacrolimus and low-dose methotrexate as GVHD prophylaxis is safe and associated with promising results in patients receiving reduced-toxicity allogeneic hematopoietic cell transplantation

Meeting Abstract

Avila, A. M.; Barba, P.; Cho, C.; Devlin, S.; Ceberio, I.; Ponce, D.; Maloy, M.; Perales, M. A.
Bone Marrow Transplantation (2016)

Fulltext@MSK | Save